Chinwag - Autumn 2019

The Christie Private Care

 Working together  for a world first

Through our joint partnership, The Christie Private Care, part of HCA Healthcare UK, has become the first healthcare provider in the world to treat a patient with hepatic

chemosaturation therapy through the radial artery in the forearm.

to show up in a scan, and because we isolate the liver, which stops 98% of the drug from spreading to other parts of the body, patients shouldn’t experience as many side effects.” Chemosaturation therapy is still a relatively new treatment and over time we hope that it will become more widely available to all patients who could benefit from this kind of therapy.

Dr Damian Mullan, consultant radiologist, who performs chemosaturation treatment

Chemosaturation is a new treatment for patients with certain types of primary and metastatic liver cancers. The treatment delivers a high dose of chemotherapy directly to the liver, helping to slow or reverse the growth of the tumours. The therapy is only currently available privately in the UK at a small number of centres. The team at The Christie Private Care was the first across the globe to administer the treatment through the radial artery, instead of via the traditional route in the groin.

explained: “We are proud to be able to offer this ground-breaking therapy, we have been able to do this via the forearm for the first time, this provides a better experience for patients and can also minimise some risks associated with this treatment. “There are many benefits of chemosaturation treatment over traditional chemotherapy; not only does it target the tumours we can see, but also those that are too small

29